Vanguard Personalized Indexing Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
|
|||||
|
2025
Q1 | $2.45M | Buy |
|
|||||
|
2024
Q4 | $2.02M | Sell |
|
|||||
|
2024
Q3 | $2.47M | Buy |
|
|||||
|
2024
Q2 | $1.74M | Buy |
|
|||||
|
2024
Q1 | $910K | Sell |
|
|||||
|
2023
Q4 | $1.22M | Buy |
|
|||||
|
2023
Q3 | $1.02M | Sell |
|
|||||
|
2023
Q2 | $1.21M | Buy |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $1.57M | Buy |
|
|||||
|
2022
Q3 | $1.17M | Buy |
|
|||||
|
2022
Q2 | $652K | Buy |
|
|||||
|
2022
Q1 | $685K | Buy |
|
|||||
|
2021
Q4 | $490K | Buy |
|
|||||
|
2021
Q3 | $463K | Buy |
|
|||||
|
2021
Q2 | $378K | Buy |
|